Patents by Inventor Seth Karp

Seth Karp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090269283
    Abstract: A method is provided for localizing an internal bleeding site whereby a protein or other factor involved in the clotting process is complexed to an imaging agent and injected into a patient believed to be at risk of internal bleeding. A clot in the patient will naturally accumulate a certain concentration of the injected complex, and within a short period of time the concentration becomes sufficient to be detected by an imaging apparatus. The imaging contrast agent may, for example, be an MRI contrast agent, a CT contrast agent, a PET agent, or a fluorescent substance.
    Type: Application
    Filed: January 5, 2009
    Publication date: October 29, 2009
    Applicant: COLD SPRING DIAGNOSTICS, INC.
    Inventors: Seth Karp, Evan Garfein, John V. Frangioni, Shunsuke Onishi
  • Publication number: 20080167544
    Abstract: The present invention relates to medical diagnostic techniques and more particularly to compositions and methods for locating an internal bleeding site in a subject.
    Type: Application
    Filed: December 3, 2007
    Publication date: July 10, 2008
    Applicant: Cold Spring Diagnostics, Inc.
    Inventors: Seth Karp, Evan Garfein
  • Publication number: 20070196278
    Abstract: The present invention relates to medical diagnostic techniques and more particularly to compositions and methods for locating an internal bleeding site in a subject.
    Type: Application
    Filed: December 4, 2006
    Publication date: August 23, 2007
    Applicant: Cold Spring Diagnostics, Inc.
    Inventors: Seth Karp, Evan Garfein
  • Publication number: 20060024229
    Abstract: A method is provided for localizing an internal bleeding site whereby a protein or other factor involved in the clotting process is complexed to an imaging agent and injected into a patient believed to be at risk of internal bleeding. A clot in the patient will naturally accumulate a certain concentration of the injected complex, and within a short period of time the concentration becomes sufficient to be detected by an imaging apparatus. The imaging contrast agent may, for example, be an MRI contrast agent, a CT contrast agent, a PET agent, or a fluorescent substance.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 2, 2006
    Inventors: Seth Karp, Evan Garfein